On August 5, 2024, Tata Elxsi, a preeminent provider of technology services, and Skanray, a well-known worldwide MedTech R&D and manufacturing company, established a strategic alliance to accelerate the development of surgical imaging software platforms and core technologies. Through the use of cutting-edge technology, our partnership promises to transform diagnosis and treatment by improving the predictability, precision, and consistency of medical processes.
Skanray is a surgical solutions, critical care, and diagnostic imaging specialist. It is constantly adding new device families and modalities to its portfolio. The company’s goal is to provide a cloud platform for advanced analytics and a set of reusable medical device modules and components. This program is a component of Skanray’s long-term plan to improve its services and deliver more complete healthcare solutions.
Recognized for its proficiency in developing software platforms, Tata Elxsi will lead the way in a software-led diagnostic approach that will support all Skanray family imaging, critical care, and surgical systems. This method guarantees multi-modal capability, compatibility, and interoperability amongst different devices. Additionally, the platform will integrate the most recent developments in Generative AI (GenAI) and Artificial Intelligence (AI), which will optimize process efficiency and enhance overall functionality.
The partnership between Skanray and Tata Elxsi leverages each company’s unique strengths: Tata Elxsi’s domain expertise in medical imaging, software platform development, cloud, artificial intelligence, and analytics, and Skanray’s in-depth knowledge of medical devices, core component technology, systems, and applications. This collaboration is further strengthened by Tata Elxsi’s ready-to-use solution accelerators, which give Skanray the means to completely reimagine the medical technology market with sophisticated, adaptable, and reasonably priced diagnostic equipment.
The head of Tata Elxsi’s Healthcare Business Unit, Pankaj Madhukar Wani, emphasized how software and digital technologies are revolutionizing diagnostic imaging. He was excited to work with Skanray to realize their long-term goals and healthcare vision. Wani stressed that the collaboration will result in revolutionary solutions for people and healthcare facilities all around the world.
Skanray Technologies Ltd.’s Vice President of Corporate Communications, Priyanka Chatterjee, agreed. She emphasized the substantial improvements in healthcare delivery that would come from fusing Tata Elxsi’s cutting-edge technological capabilities with Skanray’s core technology and medical application knowledge. Chatterjee emphasized how the partnership might result in technologically cutting-edge, user-friendly, and reasonably priced solutions, eventually enhancing patient outcomes.
With its headquarters located in Bangalore, Tata Elxsi is a multinational provider of design and technology services catering to a range of industries such as consumer electronics, broadcast, automotive, healthcare, and broadcast. The company’s Healthcare & Life Sciences practice has ISO 13485 certification and works with well-known OEMs of pharmaceuticals, medical devices, and technology. Tata Elxsi is a well-known brand in the business because of its proficiency in technology consulting, new product design and development, verification and validation, and regulatory compliance services.
The collaboration between Skanray and Tata Elxsi has the potential to propel noteworthy progress in the field of medical technology by providing inventive, scalable, and reasonably priced diagnostic solutions that will improve healthcare outcomes and delivery worldwide.
SOURCE:
ETHEALTH WORLD
